STOCKHOLM, Sept. 15, 2023 /PRNewswire/ — Sobi invites investors to participate in a virtual KOL haemophilia event on 18 September 2023 at 15:00 CEST. Guido Oelkers, Chief Executive Officer, Lydia Abad-Franch, MD, MBA, acting Chief Medical Officer, and Key Opinion Leader, Robert Klamroth,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.